We’re on WhatsApp!
Pfizer poised to buy Metsera
The pharma giant improved its offer to $10bn.
Ozempic maker lowers outlook
The company posted tepid Q3 results.
Kimberly-Clark to buy Kenvue
The deal is valued at $48.7 billion.
BYD Q3 profit down 33%
This was a 33% year-on-year decrease.
Alphabet posts first $100 bn quarter
The growth was powered by cloud division buoyed by AI